A t(2;13) translocation forms the Pax3:Fkhr fusion gene in 55%-75% of cases for the childhood muscle cancer, alveolar rhabdomyosarcoma (Sorensen et al. 2002) . This novel chimeric gene encodes for a transcription factor possessing the paired box and homeodomain DNA-binding domains from the transcription factor Pax3 fused to the potent transactivation domain of the Fkhr transcription factor (Sorensen et al. 2002) . Pax3:Fkhr is believed to result in a molecular gain of function that may initiate a deregulated muscle development program in the affected cells.
A t(2;13) translocation forms the Pax3:Fkhr fusion gene in 55%-75% of cases for the childhood muscle cancer, alveolar rhabdomyosarcoma (Sorensen et al. 2002) . This novel chimeric gene encodes for a transcription factor possessing the paired box and homeodomain DNA-binding domains from the transcription factor Pax3 fused to the potent transactivation domain of the Fkhr transcription factor (Sorensen et al. 2002) . Pax3:Fkhr is believed to result in a molecular gain of function that may initiate a deregulated muscle development program in the affected cells.
The roles of Pax3 and Pax7 are best defined in embryogenesis, where they are important transcription regulatory factors in neural tube and myogenic development (Jostes et al. 1990; Goulding et al. 1991) . Studies of Pax3-defective Splotch (Auerbach 1954) mice have revealed that Pax3 is an important determinant of p53-dependent dorsal neural tube closure (Pani et al. 2002) and an essential factor for proliferation and migration of muscle precursors from the presomitic mesoderm (Tremblay et al. 1998) . Pax7 is most closely related to Pax3, and in general parallels the expression pattern of Pax3 with a slight delay in expression onset (Jostes et al. 1990 ). Whereas Pax3-defective mice fail to form embryonic hypaxial and epaxial muscles (Tremblay et al. 1998 ), Pax7-deficient mice have grossly normal embryonic muscle mass but are impaired in the ability form muscle stem cell (satellite cell)-derived postnatal muscle (Oustanina et al. 2004) , which normally accounts for a substantial proportion of adult muscle mass.
In an accompanying paper (Keller et al. 2004) , we demonstrate that activation of Pax3:Fkhr in a target pool of Myf6+ differentiating muscle produces alveolar rhabdomyosarcoma. In this paper, we determine molecular actions of Pax3:Fkhr by studying its perturbation of wellcharacterized processes: normal mouse embryogenesis, embryonic myogenesis, and postnatal satellite cell-derived myogenesis. The in vivo functions of Pax3:Fkhr during embryogenesis also provide important insight into the potential timing and cell(s) of origin for this tumor. Most importantly, we demonstrate the surprising result that Pax3:Fkhr expression in Pax7+ satellite cells does not lead to rhabdomyosarcomas.
Results and Discussion
The conditional Pax3:Fkhr (P3Fm) knock-in allele, which allows normal Pax3 expression of that allele until Cre is present, is described in the accompanying paper (Keller et al. 2004 ) and Supplementary Figure S1A . The complementary Pax7-driven Cre allele was designed to allow Cre expression in the Pax7 expression domain without interfering with the normal Pax7 function (see Materials and Methods; Supplementary Fig. S1B ).
Pax7
ICNm/wt and Pax7 ICNm/ICNm mice are phenotypically normal and fertile. To determine whether this Cre was expressed in the expected Pax7 expression domain, lineage analysis was performed by crossing Pax7 ICNm/wt mice to ROSA26 LacZ reporter mice (Sorriano 1999) .
Doubly heterozygous Pax7
ICNm/wt Gtrosa26 tm1Sor/wt embryos were harvested at embryonic days 10 and 12 (E10 and E12) ( Supplementary Fig. S1C ,D, respectively). LacZ expression recapitulates the previously described pattern of Pax7 expression (Mansouri et al. 1996) in the somites, midface, and neural tube-derived structures. Pediatric cancers are frequently associated with chromosomal translocations, and these translocations are often asymptomatically present at birth (Greaves and Wiemels 2003) . To replicate a prenatal Pax3:Fkhr translocation for alveolar rhabdomyosarcomas, we triggered Pax3:Fkhr in the Pax3 expression domain from the earliest time point of Pax3 promoter activation by breeding conditional Pax3
P3Fm/wt mice to transgenic mice expressing Cre ubiquitously from early gestation (Schwenk et al. 1995 E10.5 embryos (see Supplementary Fig. S2 ). Pax3
P3Fa/wt RajCreTg Cre/wt mice were born in normal Mendelian ratios but displayed severe birth defects (see Fig. 1A -D and its legend). Elements of this phenotype are reminiscent of the Splotch (Auerbach 1954) and Splotch-delayed (Tremblay et al. 1998 ) homozygous mutant phenotypes. This partial phenocopy of Pax3 deficiency includes cranioschisis, exencephaly, and midface abnormalities (Tremblay et al. 1998 ) and characteristic skeletal dysplasia (see Supplemental Material; Supplementary Fig. S3 ). The hypoplastic dorsal root ganglia, normally organized but hypoplastic limb muscle, and thinned diaphragm of Pax3 P3Fa/wt RajCreTg Cre/wt mice are similar but do not fully phenocopy the absent dorsal root ganglia, absent hypaxial (limb) muscle, and absent diaphragm reported for Splotch mice (see Supplementary Fig. S4 
RajCreTg
Cre/wt mice is at least partially suppressed by the dominant-negative action of Pax3:Fkhr; however, novel features of our mice suggested that Pax3:Fkhr has additional embryonic targets as well.
We explored the midbrain overgrowth of newborn Pax3 P3Fa/wt RajCreTg Cre/wt mice to determine whether these cells had undergone hamartomatous or neoplastic transformation. By histology ( Fig. 2A,B) , the midbrain and cortex was highly disorganized. Pseudorosettes with a high mitotic index were present in an increasing caudal-to-rostral gradient within the midbrain (Fig. 2C-F) . Immunohistochemistry to determine the lineage of the pseudorosetting cells revealed that they express neuronspecific enolase (Fig. 2E) but not the markers of mature neuronal (synaptophysin, PGP9.5, S100, 68-kDa neurofilament, ␤-3-tubulin), glial (GFAP), ependymal (AE1.3), or mesenchymal (myogenin, desmin, vimentin) differentiation (data not shown). Electron microscopy revealed cells with high nuclear-to-cytoplasmic ratios without neurofilaments or other distinguishing features (data not shown). Because of the apparent undifferentiated state of these cells, we tested them for the expression of Sox1 (Fig. 2F ), a marker of primitive embryonic neural stem cells (Aubert et al. 2003) , which was positive. We therefore suggest that these ectopic, mitotically active cells represent retained primitive neuroectodermal precursors. The mitogenic effect Pax3:Fkhr has on Sox-1-expressing neural stem cells in the midbrain is especially interesting from the point of view that there may be tissue-specific cofactors that allow Pax3:Fkhr to induce proliferation in these cells but not others. This result also raises the interesting possibility that mechanisms underlying this Pax3:Fkhr-mediated neural stem cell proliferation could be elucidated and used for expansion of primitive embryonic neural stem cells in other contexts.
It is especially interesting that Pax3:Fkhr appears to ). Note cranioschisis, exencephaly, anophthalmia, omphalocoele (open arrowhead), foreshortened snout, and slightly foreshortened limbs. In the mutant, the forebrain (fb) is hypoplastic and laterally displaced by the midbrain. Note absence of the cerebellum (cb) and olfactory lobe (olf), as well as overproliferation and anteriorization of the midbrain (mb).
Conditional embryonic Pax3:Fkhr
have these previously unsuspected gain-of-function properties in tissues of the optic placode and midbrain whose patterning and development are known to be affected by other Pax family members. Although Pax2 and Pax6 expression was preserved (see Supplemental Material; Supplementary Fig. S6 ), it remains possible that Pax3:Fkhr alters expression of downstream Eya, Six, Dach, and Groucho genes that normally interact with these Pax genes during development. It will be useful to take into account the recent report of transfection experiments 
RajCreTg
Cre/wt mutant (Fig. 3D ). This absence of Pax3 transcripts and protein accounts for the similarities to the Splotch phenotype.
The mechanism for the decreased Pax3 transcript level remains to be determined; however, in Pax3:Fkhr-expressing human tumor cell lines, the level of Pax3 mRNA is fivefold lower than the level of Pax3:Fkhr mRNA (Davis and Barr 1997) despite similar RNA stabilities, suggesting a transcriptional level of action. Because Pax3 transcription is positively autoregulated by its own protein product (Ridgeway and Skerjanc 2001 ), a reasonable model for suppression of Pax3 transcription by Pax3:Fkhr is that the fusion protein negatively regulates Pax3 transcription through the Pax3 cis-autoregulatory element.
To account for the differences between the Pax3
P3Fa/wt RajCreTg Cre/wt phenotype and Splotch, we examined expression of the Pax3-related gene, Pax7, and downstream targets of Pax3. For Pax7 expression, we generated mutant and normal E11.5 embryos carrying a targeted replacement of Pax7 with LacZ (Mansouri et al. 1996) . Pax7-LacZ expression was present in the P3Fa/wt
Cre/wt mutant, but Pax3-Pax7-derived structures such as the neural tube, dorsal root ganglia, and dermomyotome were perturbed (Fig. 3E,F) . To determine whether Pax3:Fkhr may partially compensate for Pax3 loss in hypaxial muscle, we examined expression of a Pax3 downstream target gene, c-Met, in cells of the dermomyotome that migrate into the forelimb at E10.5 (Fig. 3G,H) . Despite the absence of Pax3 in the Pax3 P3Fa/wt 
Cre/wt mutant embryo, c-Met expression was increased and found to be coexpressed with the Pax3:Fkhr marker, eYFP. This result demonstrates that Pax3:Fkhr may partially compensate for Pax3 loss by transcriptional activation of some Pax3 target genes in developing hypaxial muscle. This result is also consistent with in vitro data demonstrating that c-Met is a target of Pax3:Fkhr (Ginsberg et al. 1998) . Interestingly, broad activation of the c-Met signaling pathway in conjunction with inactivation of the Ink4a/ARF locus results in non-alveolar rhabdomyosarcomas in mice at high frequency (Sharp et al. 2002) .
To study the consequences of later embryonic activation of Pax3:Fkhr in the overlap of Pax3 and Pax7 expression domains, we bred conditional Pax3:Fkhr mice to Pax7-Cre mice. Pax3
P3Fa/wt Pax7 ICNm/wt pups were represented at normal Mendelian ratios and displayed the mild birth defects of a narrowed nose (Fig. 4A) wk, at which time they weighed less than one-third of their unaffected littermates (Fig. 4B) . The reduced weight of the postnatal day 21 (P21) neonates is primarily the result of extreme reduction of muscle mass (Fig. 4C) , with an accompanying mild reduction in myofiber diameter by histology (data not shown). To determine whether this reduction in muscle mass was a consequence of reduced satellite cells (Oustanina et al. 2004 ), electron microscopy was performed, revealing that satellite cells were present in normal weight Pax3 P3Fa/wt 
Pax7
ICNm/wt mutant P0 pups (Fig. 4D ), but in fewer numbers than control littermates. To determine more precisely whether the number of satellite cells was reduced in Pax3 P3Fa/wt Pax7 ICNm/wt mice postnatally, we harvested the vastus lateralis muscle of P9 mouse pups and performed Pax7 immunohistochemistry to detect satellite cells, counterstaining myofiber nuclei with DAPI (Fig. 4E) . We found a significant reduction in the percentage of satellite cells for mutant muscle compared with normal (10% vs. 15.2%, p < 0.001, n = 11,805 nonvessel nuclei counted). Myofiber density was significantly higher in mutants as compared with normals (515 vs. 349 cells per field, p < 0.001) as a result of reduced cross-sectional area of individual myofibers (affected myofiber cross-sectional area was 68% of control), which is similar to findings for Pax7 −/− mice (Oustanina et al. 2004) . The proportion of activated myoblasts coexpressing Pax7 and Myogenin in mutant and control mice appear comparable (data not shown); however, immunohistochemical staining for NCAM, a cell surface marker of myofibers that have undergone fusion with a satellitecell-derived myoblast (Covault et al. 1986 ), showed severely reduced NCAM expression at the surface of mature myofibers from Pax3
P3Fa/wt Pax7 ICNm/wt mutant mice (Fig. 4F) . Taken together, these results suggest that the small myofiber diameter at P21 is a result of the smaller satellite cell pool that is impaired in self-renewal capacity as are Pax7 −/− mice (Oustanina et al. 2004 ), resulting in fewer satellite-cell-derived activated myoblasts being available to fuse with existing mature myofibers. This functional defect appears to have been present at birth but was significantly exacerbated postnatally.
For the midface defects, computed tomography scan at P21 demonstrated maxillary and lacrimal bone hypoplasia, agenesis of the rostral premaxilla, and severely underdeveloped nasal turbinates relative to control littermates (Fig. 4G,H) . Because of the increased work of breathing associated with a collapsible nasal airway, only a limited number of Pax3 P3Fa/wt Pax7 ICNm/wt mice have survived to 3.5 mo of age (lethality was in part ameliorated by serial fostering followed by weaning to a gel-based source of hydration). None of these animals having ubiquitous Pax3:Fkhr rearrangements in their Pax7+ satellite cells developed alveolar rhabdomyosarcoma; this is a remarkable observation, because it is widely thought that alveolar rhabdomyosarcomas arise from satellite cells.
Collectively, the reduced muscle mass, maxillary and lacrimal bone hypoplasia, and nasal turbinate abnormalities of Pax3 P3Fa/wt Pax7 ICNm/wt mice strongly suggest a phenocopy of the Pax7 deficiency (Mansouri et al. 1996; Oustanina et al. 2004) . To determine whether the Pax3:Fkhr allele was directly suppressing Pax7 transcription, we bred a ROSA26 LacZ reporter gene (Sorriano 1999) into Pax3 P3Fa/wt Pax7 ICNm/wt mutant mice and controls to act as a readout of Pax7 promoter activity and cell survival in E10.5 and E11.5 embryos (Fig. 5A-D) . We encountered a range of LacZ reporter activity for which the Pax7 promoter activity of Pax3 P3Fa/wt Pax7
ICNm/wt mice was either equivalent or increased as compared with Pax3 wt/wt Pax7 ICNm/wt control mice. An example of increased activity is shown in Figure 5A ICNm/wt E10.5 embryos (Fig. 5E,F (Fig. 5G,H) . This Pax7 knockout phenocopy, despite increased Pax7 expression, could be explained by dominant-negative effects of Pax3:Fkhr on Pax7 targets, rather than effects on expression of Pax7 itself. Unfortunately, at present downstream targets unique to Pax7 but not shared by Pax3 remain to be identified. A working model for how Pax3:Fkhr modulates Pax3, Pax7, and other downstream targets is shown in Supplementary Figure S7 .
Recent transfection studies have shown that in embryonal rhabdomyosarcoma cells forced to express the alveolar rhabdomyosarcoma oncogene Pax3:Fkhr, Pax3 levels are increased and Pax7 levels are decreased (Tomescu et al. 2004) . We have no clear explanation for the differences between this study and ours, except to suggest that embryonal rhabdomyosarcomas may not be the starting point or an equivalent cellular context for alveolar rhabdomyosarcomas.
In important previous studies, germ-line expression of the Pax3:Fkhr fusion gene under the control of the Pax3 promoter has resulted in embryonic lethality without midbrain overproliferation, anophthalmia, or forebrain abnormalities (for references and comparisons, see Supplementary Table 1) . In several instances, the other models represent hypomorphs of the early embryonic activation of our conditional model. However, each of these Pax3:Fkhr alleles had design differences such as being a transgene or being constructed from an incomplete cDNA instead of genomic DNA that may have affected the spectrum of Pax3:Fkhr activities in separate tissues. In our conditional knock-in model, we closely recapitulate the cis-regulatory changes caused by the real translocation in human tumors. At the time of Cre expression, we remove the 3 kb of Pax3 containing exons 8-10 and juxtapose a previously silent 9.3-kb genomic fragment of Fkhr containing exons 2 and 3 and the full 3Ј-untranslated region. By using murine genomic DNA from both Pax3 and Fkhr, we avoided potential complications of species-specific regulatory element sequence. The value of this approach is demonstrated by the markedly different phenotypes we see in our mice with early embryonic activation of Pax3:Fkhr. Furthermore, with this conditional model we have the added advantage of studying the effects of Pax3:Fkhr at midgestation, thereby bypassing the earlier Pax3:Fkhr expression that we show results in massive perturbation of the central nervous system. The later, less severe (yet intriguing) phenocopy of Pax7 deficiency we report here allows for closer comparisons of gene expression levels in tissues whose structures are not so severely perturbed.
With regard to the timing and cell of origin for human tumors possessing Pax3:Fkhr translocations, the severity of birth defects in Pax3 P3Fa/wt RajCreTg Cre/wt or Pax3 P3Fa/wt Pax7 ICNm/wt mice and associated lethality suggests that the translocation event in humans is unlikely to occur either as a germ-line mutation or as a mosaic in a broad range of embryonic myogenic precursors. One could speculate that a small subset of embryonically or postnatally derived Pax3/Pax7-coexpressing satellite cells could give rise to an alveolar rhabdomyosarcoma; however, our results demonstrate that Pax3 P3Fa/wt 
ICNm/wt mice carrying the activated Pax3:Fkhr allele in the entire Pax7+ subcompartment of the satellite cell pool do not develop tumors even up to 3.5 mo of age, well into the young adulthood of these mice. This unexpected result that Pax7+ satellite cells do not give rise to alveolar rhabdomyosarcomas is made more remarkable by the observation in the accompanying paper (Keller et al. 2004 ) that Pax3:Fkhr activation in a target pool of Myf6+ differentiating myofibers leads to alveolar rhabdomyosarcoma tumors. These provocative findings, that mature differentiating skeletal muscle and not satellite cells gives rise to alveolar rhabdomyosarcomas, asks us to reconsider the widely held assumption that only muscle stem cells give rise to rhabdomyosarcomas.
Materials and methods

Isolation of genomic clones
A 21-kb genomic clone spanning exon 8 to the 3Ј-untranslated region of Pax7 was isolated from a bacteriophage library of mouse strain SvJ-129 (Stratagene). 
